Induction of Osteoclast Differentiation by Runx2 through Receptor Activator of Nuclear Factor-κB Ligand (RANKL) and Osteoprotegerin Regulation and Partial Rescue of Osteoclastogenesis in Runx2–/– Mice by RANKL Transgene
Hirayuki Enomoto(Hyogo Medical University), Toshihisa Komori(Nagasaki University), Ryo Fukuyama(Setsunan University), Tatsuya Furuichi(Iwate University), Satoko Shiojiri(The University of Osaka), Akira Zanma(Teijin (Japan)), Naoko Kanatani(The University of Osaka), Hisataka Yasuda(SHOWA Medical University), Atsuko Mizuno(Megmilk Snow Brand (Japan)), Kenji Takada(The University of Osaka), Kazuki Yano(SHOWA Medical University), Reiko Nakamura(Keio University), Kazuto Hoshi(The University of Tokyo), Carolina A. Yoshida(The University of Osaka), Kanji Higashio(Megmilk Snow Brand (Japan))
Cited by 163
Related Papers
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
|Proceedings of the National Academy of Sciences|1998|4.3k
Tumor Necrosis Factor α Stimulates Osteoclast Differentiation by a Mechanism Independent of the Odf/Rankl–Rank Interaction
|The Journal of Experimental Medicine|2000|1.3k
Identity of Osteoclastogenesis Inhibitory Factor (OCIF) and Osteoprotegerin (OPG): A Mechanism by which OPG/OCIF Inhibits Osteoclastogenesis<i>in Vitro</i><sup>1</sup>
|Endocrinology|1998|1.2k
Regulation of Proliferation, Differentiation and Functions of Osteoblasts by Runx2
|International Journal of Molecular Sciences|2019|812
Regulation of bone development and extracellular matrix protein genes by RUNX2
|Cell and Tissue Research|2009|799